Ryaltris 25 µg/dose - 600 µg/dose (PI Pharma) nas. spray susp. met. pump 29 g (240 doses)
Active ingredient: Olopatadine ,Mometasone Furoate
View notice details →
News topic
Current shortage notices for the product family Ryaltris, structured by product, country and reporting period.
1 noticesActive ingredient: Olopatadine ,Mometasone Furoate
View notice details →For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.
Researching this shortage professionally? We assess sourcing routes, suppliers and cross-border supply against your requirements. A notice does not confirm stock availability.
Send a sourcing enquiry →Medicine storage, batch and expiry control, picking and distribution for Germany and Europe. We agree the storage profile, temperature and capacity with you.
Request warehouse capacity →